Stay updated on Pembrolizumab vs Brentuximab in Hodgkin Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab vs Brentuximab in Hodgkin Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab vs Brentuximab in Hodgkin Lymphoma Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The page footer revision updated from v3.3.3 to v3.3.4; no changes to study details, eligibility criteria, or results. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T03:54:59.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    Label for the update timestamp changed from 'Last Update Posted' to 'Last Update Posted (Estimated)'. This is a minor labeling change to the update date display and does not alter study information; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-31T00:22:13.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    Study status updated to Completed with new completion dates. The previous 'Active, not recruiting' status was removed, and the page shows Revision: v3.3.3.
    Difference
    0.6%
    Check dated 2025-12-23T21:27:49.000Z thumbnail image
  5. Check
    56 days ago
    Change Detected
    Summary
    Editorial updates to the Publications section clarify that PubMed publications are automatically filled and reflect a revision label change from v3.2.0 to v3.3.2; no core study content is altered. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T11:52:26.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    The government funding outage notice on the page has been removed, leaving the standard study information as the primary content.
    Difference
    0.4%
    Check dated 2025-11-18T07:15:10.000Z thumbnail image
  7. Check
    77 days ago
    Change Detected
    Summary
    No substantive updates to the study design, eligibility criteria, primary or secondary outcomes, or sponsor were observed; only minor UI and wording adjustments were detected. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T21:17:49.000Z thumbnail image

Stay in the know with updates to Pembrolizumab vs Brentuximab in Hodgkin Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Brentuximab in Hodgkin Lymphoma Clinical Trial page.